Mayne Pharma Group
OTCMKTS:MAYNFMayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
PGIM Active Aggregate Bond ETF
NYSEARCA:PABThe PGIM Active Aggregate Bond ETF (PAB) is an exchange-traded fund that is based on the Bloomberg US Aggregate Bond index. The fund is an actively managed fixed income fund that holds USD-denominated securities issued by both government and corporate entities. These securities must be investment grade and have maturities of more than one year. PAB was launched on Apr 15, 2021 and is managed by PGIM.